16th Community Wide Experiment on the
Critical Assessment of Techniques for Protein Structure Prediction
Ligand Predictions Analysis
Results Home Table Browser
Target: 
Text
Models / Ligands Ligand scores
    #     Model     Group
    Name
     Target Ligand     LDDT_pli     RMSD     LDDT_lp     BB_RMSD
1. L3085LG204_2 Zou ligand_L0R_1_1_A.mol 0.820 1.002 0.927 0.461
2. L3085LG420_1 Zou_aff2 ligand_L0R_1_1_A.mol 0.820 1.002 0.927 0.461
3. L3085LG420_3 Zou_aff2 ligand_L0R_1_1_B.mol 0.793 1.589 0.872 0.557
4. L3085LG055_2 LCDD-team ligand_L0R_1_1_B.mol 0.770 1.823 0.939 0.266
5. L3085LG420_2 Zou_aff2 ligand_L0R_1_1_B.mol 0.754 1.982 0.949 0.397
6. L3085LG204_4 Zou ligand_L0R_1_1_B.mol 0.754 1.982 0.949 0.397
7. L3085LG420_5 Zou_aff2 ligand_L0R_1_1_B.mol 0.746 2.082 0.886 0.547
8. L3085LG420_4 Zou_aff2 ligand_L0R_1_1_A.mol 0.706 1.414 0.807 1.006
9. L3085LG227_1 KUMC ligand_L0R_1_1_B.mol 0.604 2.868 0.961 0.361
10. L3085LG055_3 LCDD-team ligand_L0R_1_1_B.mol 0.573 5.977 0.939 0.266
11. L3085LG408_5 SNU-CHEM-lig ligand_L0R_1_1_B.mol 0.571 6.058 0.884 0.502
12. L3085LG408_3 SNU-CHEM-lig ligand_L0R_1_1_A.mol 0.564 6.389 0.907 0.360
13. L3085LG227_4 KUMC ligand_L0R_1_1_A.mol 0.543 3.208 0.965 0.319
14. L3085LG408_4 SNU-CHEM-lig ligand_L0R_1_1_A.mol 0.543 6.211 0.806 0.689
15. L3085LG016_4 haiping ligand_L0R_1_1_B.mol 0.535 6.405 0.945 0.449
16. L3085LG207_2 MULTICOM_ligand ligand_L0R_1_1_B.mol 0.534 6.498 0.944 0.457
17. L3085LG408_1 SNU-CHEM-lig ligand_L0R_1_1_A.mol 0.530 6.554 0.914 0.299
18. L3085LG055_1 LCDD-team ligand_L0R_1_1_B.mol 0.521 6.261 0.939 0.266
19. L3085LG207_3 MULTICOM_ligand ligand_L0R_1_1_B.mol 0.521 6.567 0.944 0.457
20. L3085LG055_5 LCDD-team ligand_L0R_1_1_B.mol 0.521 6.046 0.939 0.266
21. L3085LG055_4 LCDD-team ligand_L0R_1_1_A.mol 0.516 4.855 0.939 0.266
22. L3085LG432_3 DIMAIO ligand_L0R_1_1_A.mol 0.516 6.743 0.941 0.275
23. L3085LG016_1 haiping ligand_L0R_1_1_B.mol 0.513 6.836 0.945 0.449
24. L3085LG432_5 DIMAIO ligand_L0R_1_1_B.mol 0.513 6.314 0.828 0.779
25. L3085LG091_4 Huang-HUST ligand_L0R_1_1_B.mol 0.507 6.310 0.923 0.201
26. L3085LG091_1 Huang-HUST ligand_L0R_1_1_B.mol 0.503 6.495 0.869 0.633
27. L3085LG016_2 haiping ligand_L0R_1_1_B.mol 0.497 7.045 0.945 0.449
28. L3085LG082_1 VnsDock ligand_L0R_1_1_A.mol 0.497 3.667 0.943 0.395
29. L3085LG091_5 Huang-HUST ligand_L0R_1_1_B.mol 0.491 6.530 0.880 0.638
30. L3085LG294_1 KiharaLab ligand_L0R_1_1_A.mol 0.491 7.012 0.950 0.444
31. L3085LG494_5 ClusPro ligand_L0R_1_1_A.mol 0.482 6.830 0.856 0.444
32. L3085LG274_5 kozakovvajda ligand_L0R_1_1_A.mol 0.482 6.830 0.856 0.444
33. L3085LG262_4 CoDock ligand_L0R_1_1_A.mol 0.480 4.311 0.802 0.761
34. L3085LG207_5 MULTICOM_ligand ligand_L0R_1_1_B.mol 0.476 6.914 0.825 0.838
35. L3085LG408_2 SNU-CHEM-lig ligand_L0R_1_1_A.mol 0.476 6.823 0.861 0.523
36. L3085LG207_1 MULTICOM_ligand ligand_L0R_1_1_B.mol 0.474 6.677 0.944 0.457
37. L3085LG274_3 kozakovvajda ligand_L0R_1_1_B.mol 0.472 6.617 0.859 0.444
38. L3085LG494_3 ClusPro ligand_L0R_1_1_B.mol 0.472 6.617 0.859 0.444
39. L3085LG091_2 Huang-HUST ligand_L0R_1_1_B.mol 0.472 6.772 0.923 0.201
40. L3085LG494_1 ClusPro ligand_L0R_1_1_A.mol 0.471 6.933 0.857 0.444
41. L3085LG274_1 kozakovvajda ligand_L0R_1_1_A.mol 0.471 6.933 0.857 0.444
42. L3085LG262_1 CoDock ligand_L0R_1_1_A.mol 0.457 7.029 0.851 0.445
43. L3085LG262_2 CoDock ligand_L0R_1_1_B.mol 0.456 6.751 0.851 0.445
44. L3085LG494_4 ClusPro ligand_L0R_1_1_B.mol 0.455 6.732 0.857 0.444
45. L3085LG274_4 kozakovvajda ligand_L0R_1_1_B.mol 0.455 6.732 0.857 0.444
46. L3085LG201_1 Drugit ligand_L0R_1_1_A.mol 0.436 4.423 0.809 0.690
47. L3085LG091_3 Huang-HUST ligand_L0R_1_1_B.mol 0.426 6.838 0.923 0.201
48. L3085LG494_2 ClusPro ligand_L0R_1_1_A.mol 0.415 6.895 0.856 0.444
49. L3085LG274_2 kozakovvajda ligand_L0R_1_1_A.mol 0.415 6.895 0.856 0.444
50. L3085LG008_5 HADDOCK ligand_L0R_1_1_A.mol 0.412 7.085 0.904 0.523
51. L3085LG309_3 Koes ligand_L0R_1_1_B.mol 0.402 4.231 0.606 1.852
52. L3085LG432_1 DIMAIO ligand_L0R_1_1_B.mol 0.388 5.599 0.865 0.580
53. L3085LG016_5 haiping ligand_L0R_1_1_B.mol 0.384 6.034 0.945 0.449
54. L3085LG008_3 HADDOCK ligand_L0R_1_1_A.mol 0.383 7.351 0.888 0.692
55. L3085LG201_3 Drugit ligand_L0R_1_1_A.mol 0.365 5.279 0.801 0.725
56. L3085LG201_4 Drugit ligand_L0R_1_1_B.mol 0.337 6.287 0.801 0.731
57. L3085LG309_4 Koes ligand_L0R_1_1_B.mol 0.319 6.720 0.655 1.708
58. L3085LG227_3 KUMC ligand_L0R_1_1_A.mol 0.309 5.829 0.961 0.361
59. L3085LG298_5 ShanghaiTech-human ligand_L0R_1_1_A.mol 0.293 5.944 0.952 0.451
60. L3085LG386_5 ShanghaiTech-Ligand ligand_L0R_1_1_A.mol 0.293 5.944 0.952 0.451
61. L3085LG191_3 Schneidman ligand_L0R_1_1_A.mol 0.290 5.459 0.593 2.042
62. L3085LG432_2 DIMAIO ligand_L0R_1_1_A.mol 0.290 6.508 0.872 0.273
63. L3085LG309_2 Koes ligand_L0R_1_1_A.mol 0.272 5.306 0.659 1.701
64. L3085LG191_1 Schneidman ligand_L0R_1_1_B.mol 0.266 4.949 0.627 1.853
65. L3085LG262_3 CoDock ligand_L0R_1_1_B.mol 0.260 8.527 0.793 0.853
66. L3085LG204_1 Zou ligand_L0R_1_1_B.mol 0.259 6.545 0.953 0.420
67. L3085LG298_3 ShanghaiTech-human ligand_L0R_1_1_A.mol 0.258 6.443 0.952 0.451
68. L3085LG386_3 ShanghaiTech-Ligand ligand_L0R_1_1_A.mol 0.258 6.443 0.952 0.451
69. L3085LG167_1 OpenComplex ligand_L0R_1_1_A.mol 0.256 6.694 0.511 2.887
70. L3085LG167_2 OpenComplex ligand_L0R_1_1_A.mol 0.254 6.496 0.677 1.437
71. L3085LG298_4 ShanghaiTech-human ligand_L0R_1_1_A.mol 0.244 6.702 0.952 0.451
72. L3085LG386_4 ShanghaiTech-Ligand ligand_L0R_1_1_A.mol 0.244 6.702 0.952 0.451
73. L3085LG450_4 OpenComplex_Server ligand_L0R_1_1_B.mol 0.240 7.843 0.881 0.679
74. L3085LG450_5 OpenComplex_Server ligand_L0R_1_1_B.mol 0.234 8.095 0.881 0.679
75. L3085LG309_1 Koes ligand_L0R_1_1_B.mol 0.223 6.832 0.650 1.718
76. L3085LG432_4 DIMAIO ligand_L0R_1_1_A.mol 0.218 7.604 0.921 0.465
77. L3085LG450_1 OpenComplex_Server ligand_L0R_1_1_B.mol 0.204 8.194 0.881 0.679
78. L3085LG164_1 McGuffin ligand_L0R_1_1_A.mol 0.190 8.537 0.659 1.663
79. L3085LG262_5 CoDock ligand_L0R_1_1_B.mol 0.190 7.993 0.802 0.761
80. L3085LG386_1 ShanghaiTech-Ligand ligand_L0R_1_1_A.mol 0.186 7.288 0.939 0.457
81. L3085LG298_1 ShanghaiTech-human ligand_L0R_1_1_A.mol 0.186 7.288 0.939 0.457
82. L3085LG164_4 McGuffin ligand_L0R_1_1_B.mol 0.183 8.065 0.659 1.663
83. L3085LG016_3 haiping ligand_L0R_1_1_B.mol 0.182 9.512 0.945 0.449
84. L3085LG450_3 OpenComplex_Server ligand_L0R_1_1_B.mol 0.182 8.951 0.881 0.679
85. L3085LG008_4 HADDOCK ligand_L0R_1_1_A.mol 0.181 9.422 0.894 0.654
86. L3085LG204_5 Zou ligand_L0R_1_1_B.mol 0.180 9.637 0.939 0.427
87. L3085LG164_3 McGuffin ligand_L0R_1_1_A.mol 0.180 8.677 0.659 1.663
88. L3085LG008_2 HADDOCK ligand_L0R_1_1_A.mol 0.178 9.817 0.875 0.664
89. L3085LG204_3 Zou ligand_L0R_1_1_A.mol 0.176 7.771 0.939 0.422
90. L3085LG298_2 ShanghaiTech-human ligand_L0R_1_1_B.mol 0.172 9.592 0.952 0.451
91. L3085LG386_2 ShanghaiTech-Ligand ligand_L0R_1_1_B.mol 0.172 9.592 0.952 0.451
92. L3085LG227_2 KUMC ligand_L0R_1_1_A.mol 0.170 8.963 0.965 0.319
93. L3085LG008_1 HADDOCK ligand_L0R_1_1_A.mol 0.168 9.064 0.917 0.577
94. L3085LG164_5 McGuffin ligand_L0R_1_1_B.mol 0.164 7.718 0.659 1.663
95. L3085LG207_4 MULTICOM_ligand ligand_L0R_1_1_B.mol 0.161 9.263 0.857 0.766
96. L3085LG227_5 KUMC ligand_L0R_1_1_A.mol 0.157 9.189 0.965 0.319
97. L3085LG450_2 OpenComplex_Server ligand_L0R_1_1_A.mol 0.157 8.632 0.903 0.616
98. L3085LG167_4 OpenComplex ligand_L0R_1_1_A.mol 0.140 9.260 0.567 1.484
99. L3085LG201_2 Drugit ligand_L0R_1_1_A.mol 0.109 9.629 0.783 0.548
100. L3085LG464_3 PocketTracer ligand_L0R_1_1_B.mol 0.079 13.040 0.649 1.792
101. L3085LG201_5 Drugit ligand_L0R_1_1_A.mol 0.068 10.280 0.826 0.592
102. L3085LG464_2 PocketTracer ligand_L0R_1_1_B.mol 0.036 14.633 0.649 1.792
103. L3085LG464_1 PocketTracer ligand_L0R_1_1_B.mol 0.033 12.777 0.649 1.792
104. L3085LG167_5 OpenComplex ligand_L0R_1_1_A.mol 0.031 13.839 0.499 3.444
105. L3085LG464_4 PocketTracer ligand_L0R_1_1_B.mol 0.015 16.348 0.649 1.792
106. L3085LG464_5 PocketTracer ligand_L0R_1_1_B.mol 0.010 16.244 0.649 1.792
107. L3085LG164_2 McGuffin ligand_L0R_1_1_B.mol 0.000 32.843 0.664 1.670
108. L3085LG167_3 OpenComplex ligand_L0R_1_1_B.mol 0.000 18.667 0.556 2.074
Protein Structure Prediction Center
Sponsored by the US National Institute of General Medical Sciences (NIH/NIGMS)
Please address any questions or queries to:
© 2007-2024, University of California, Davis
Terms of Use